185 related articles for article (PubMed ID: 26238458)
1. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.
Stepien M; Duarte-Salles T; Fedirko V; Floegel A; Barupal DK; Rinaldi S; Achaintre D; Assi N; Tjønneland A; Overvad K; Bastide N; Boutron-Ruault MC; Severi G; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Bamia C; Lagiou P; Saieva C; Agnoli C; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Dorronsoro M; Gavrila D; Barricarte A; Ohlsson B; Sjöberg K; Werner M; Sund M; Wareham N; Khaw KT; Travis RC; Schmidt JA; Gunter M; Cross A; Vineis P; Romieu I; Scalbert A; Jenab M
Int J Cancer; 2016 Jan; 138(2):348-60. PubMed ID: 26238458
[TBL] [Abstract][Full Text] [Related]
2. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.
Hughes DJ; Duarte-Salles T; Hybsier S; Trichopoulou A; Stepien M; Aleksandrova K; Overvad K; Tjønneland A; Olsen A; Affret A; Fagherazzi G; Boutron-Ruault MC; Katzke V; Kaaks R; Boeing H; Bamia C; Lagiou P; Peppa E; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Peeters PH; Engeset D; Weiderpass E; Lasheras C; Agudo A; Sánchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Hemmingsson O; Wareham NJ; Khaw KT; Bradbury KE; Cross AJ; Gunter M; Riboli E; Romieu I; Schomburg L; Jenab M
Am J Clin Nutr; 2016 Aug; 104(2):406-14. PubMed ID: 27357089
[TBL] [Abstract][Full Text] [Related]
4. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans.
Stepien M; Hughes DJ; Hybsier S; Bamia C; Tjønneland A; Overvad K; Affret A; His M; Boutron-Ruault MC; Katzke V; Kühn T; Aleksandrova K; Trichopoulou A; Lagiou P; Orfanos P; Palli D; Sieri S; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Lasheras C; Bonet Bonet C; Molina-Portillo E; Dorronsoro M; Huerta JM; Barricarte A; Ohlsson B; Sjöberg K; Werner M; Shungin D; Wareham N; Khaw KT; Travis RC; Freisling H; Cross AJ; Schomburg L; Jenab M
Br J Cancer; 2017 Feb; 116(5):688-696. PubMed ID: 28152549
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
[TBL] [Abstract][Full Text] [Related]
6. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
Aleksandrova K; Boeing H; Nöthlings U; Jenab M; Fedirko V; Kaaks R; Lukanova A; Trichopoulou A; Trichopoulos D; Boffetta P; Trepo E; Westhpal S; Duarte-Salles T; Stepien M; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Dossus L; Racine A; Lagiou P; Bamia C; Benetou V; Agnoli C; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita B; Peeters PH; Gram IT; Lund E; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Gavrila D; Barricarte A; Dorronsoro M; Ohlsson B; Lindkvist B; Johansson A; Sund M; Khaw KT; Wareham N; Travis RC; Riboli E; Pischon T
Hepatology; 2014 Sep; 60(3):858-71. PubMed ID: 24443059
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
[TBL] [Abstract][Full Text] [Related]
9. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers.
Man XB; Tang L; Zhang BH; Li SJ; Qiu XH; Wu MC; Wang HY
Liver Int; 2005 Oct; 25(5):962-6. PubMed ID: 16162153
[TBL] [Abstract][Full Text] [Related]
11. Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study.
Baumeister SE; Schlesinger S; Aleksandrova K; Jochem C; Jenab M; Gunter MJ; Overvad K; Tjønneland A; Boutron-Ruault MC; Carbonnel F; Fournier A; Kühn T; Kaaks R; Pischon T; Boeing H; Trichopoulou A; Bamia C; La Vecchia C; Masala G; Panico S; Fasanelli F; Tumino R; Grioni S; Bueno de Mesquita B; Vermeulen R; May AM; Borch KB; Oyeyemi SO; Ardanaz E; Rodríguez-Barranco M; Dolores Chirlaque López M; Felez-Nobrega M; Sonestedt E; Ohlsson B; Hemmingsson O; Werner M; Perez-Cornago A; Ferrari P; Stepien M; Freisling H; Tsilidis KK; Ward H; Riboli E; Weiderpass E; Leitzmann MF
J Hepatol; 2019 May; 70(5):885-892. PubMed ID: 30582978
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract.
Cabibi D; Licata A; Barresi E; Craxì A; Aragona F
Pathol Res Pract; 2003; 199(2):65-70. PubMed ID: 12747467
[TBL] [Abstract][Full Text] [Related]
13. Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study.
Ryu S; Chang Y; Yun KE; Jung HS; Shin JH; Shin H
Am J Gastroenterol; 2016 Oct; 111(10):1476-1487. PubMed ID: 27575712
[TBL] [Abstract][Full Text] [Related]
14. [Tumor grading of the hepatobiliary system].
Jütte H; Tannapfel A
Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
[TBL] [Abstract][Full Text] [Related]
15. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies.
Petrick JL; Florio AA; Koshiol J; Pfeiffer RM; Yang B; Yu K; Chen CJ; Yang HI; Lee MH; McGlynn KA
Int J Cancer; 2020 Nov; 147(10):2743-2753. PubMed ID: 32406072
[TBL] [Abstract][Full Text] [Related]
16. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1.
Magerl C; Ellinger J; Braunschweig T; Kremmer E; Koch LK; Höller T; Büttner R; Lüscher B; Gütgemann I
Hum Pathol; 2010 Feb; 41(2):181-9. PubMed ID: 19896696
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
18. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
19. Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.
Hemminki K; Sundquist K; Sundquist J; Försti A; Liska V; Hemminki A; Li X
Int J Cancer; 2023 Mar; 152(6):1107-1114. PubMed ID: 36196489
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma.
Huang BY; Tsai MR; Hsu JK; Lin CY; Lin CL; Hu JT; Huang YW; Liu CJ; Wu WJ; Wu CF; Sung FY; Chen PJ; Liang HJ; Lin SM; Yu MW
Mol Carcinog; 2020 Nov; 59(11):1269-1279. PubMed ID: 32914490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
